Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely developed TPD procedures. On this evaluation, we concentrate on both of those preclinical experiments and medical trials to deliver an extensive summary of the safety and medical effectiveness of PROTACs and MGDs in hematologic malignancies in the https://georget752lqv6.verybigblog.com/profile